[](//www.DrugPatentWatch.com/p/preview/generic-api/posaconazole?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog)
Posaconazole is the generic ingredient in three branded drugs marketed by Msd Merck Co, Merck Sharp Dohme, Par Sterile Products, Schering, Hikma, Actavis Labs Fl Inc, Aet Pharma, Amneal, Biocon Pharma, Dr Reddys, Hetero Labs Ltd Iii, Sinotherapeutics Inc, and Specgx Llc and, and is included in fourteen NDAs. There are seven patents protecting this compound.
Drug patent litigation for POSACONAZOLE.
This ingredient has ninety-six patent family members in twenty-eight countries.
Twenty suppliers are listed for this compound. There are two tentative approvals for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
